Audience: Partners

Learn more about the collaborative efforts of the Center for Data Driven Discovery in Biomedicine (D³b) to unify annotated clinical and genomic data to provide personalized and targeted care for every patient.  Find out how you can partner to support this life-saving research.

NF2 Biosolutions

Background Neurofibromatosis 2 (NF2) is a rare genetic disorder that is primarily characterized by noncancerous (benign) tumors of the nerves that transmit balance and sound impulses from the…

Chordoma Foundation Biobank

Background The Chordoma Foundation (CF) biospecimens, clinical and genomic data via the expertise and tools created by the Center for Data Driven Discovery (D3b) at the Children’s Hospital…

Oligo Nation

Oligodendroglioma Oligodendroglioma (Oligo) is a primary malignant brain cancer that develops from Oligodendrocytes. Oligodendroglioma is one of the more common types of glioma (which also includes Glioblastoma Multiforme…

CHOP’s Center for Data Driven Discovery in Biomedicine Joins the Division of Neurosurgery and Neuro-Oncology Program to Honor Brain Tumor Awareness Month

According to the Central Brain Tumor Registry of the United States (CBTRUS), an estimated 86,970 new cases of primary malignant and non-malignant brain and central nervous system (CNS)…

#BrainTumorAwarenessMonth: Increased Support of Collaborative Brain Tumor Research is Critical to Improving Treatments and Discovering Cures for Children

*Note: This article comes courtesy of the Children’s Brain Tumor Network (CBTN), for which the Center for Data Drive Discovery in Biomedicine is the operations center.  The CBTN…